3-119437901-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018266.3(TMEM39A):āc.778A>Gā(p.Thr260Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00054 in 1,613,572 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018266.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM39A | NM_018266.3 | c.778A>G | p.Thr260Ala | missense_variant | 6/9 | ENST00000319172.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM39A | ENST00000319172.10 | c.778A>G | p.Thr260Ala | missense_variant | 6/9 | 1 | NM_018266.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000390 AC: 98AN: 251342Hom.: 0 AF XY: 0.000456 AC XY: 62AN XY: 135830
GnomAD4 exome AF: 0.000560 AC: 818AN: 1461456Hom.: 1 Cov.: 31 AF XY: 0.000605 AC XY: 440AN XY: 726952
GnomAD4 genome AF: 0.000355 AC: 54AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.778A>G (p.T260A) alteration is located in exon 6 (coding exon 5) of the TMEM39A gene. This alteration results from a A to G substitution at nucleotide position 778, causing the threonine (T) at amino acid position 260 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at